Ri. Glass et al., THE EPIDEMIOLOGY OF ROTAVIRUS DIARRHEA IN THE UNITED-STATES - SURVEILLANCE AND ESTIMATES OF DISEASE BURDEN, The Journal of infectious diseases, 174, 1996, pp. 5-11
The decision to develop rotavirus vaccines was predicated on the exten
sive burden of rotavirus disease among children worldwide. US reports
on nationwide hospitalizations (1979-1992) and deaths (1968-1991) due
to diarrhea and weekly reports of rotavirus infection by 74 laboratori
es were reviewed to estimate the burden of rotavirus disease, identify
epidemiologic trends, and consider methods for evaluating an immuniza
tion program when a vaccine becomes available. From 1968 to 1985, diar
rhea-related deaths among US children <5 years old declined from 1100
to 300/year. This decline was associated with the disappearance of win
ter peaks for diarrhea-related deaths previously associated with rotav
irus infection among children 4-23 months old. From 1979 to 1992, howe
ver, hospitalizations for diarrhea averaged 186,000/year and retained
their winter peaks, which have been linked to rotavirus infections. Ea
ch year an estimated 54,000-55,000 US children are hospitalized for di
arrhea, but <40 die with rotavirus. A rotavirus vaccine program will r
equire improved surveillance, including the timely collection of data
from sentinel hospitals, in which a diagnosis of rotavirus can be esta
blished or ruled out for all children hospitalized for diarrhea.